• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同模型中帕金森病的建模

Modeling of Parkinson's Disease in Different Models.

作者信息

Subhan Iqra, Siddique Yasir Hasan

机构信息

Laboratory of Alternative Animal Models, Section of Genetics, Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, 202002, Uttar Pradesh, India.

出版信息

CNS Neurol Disord Drug Targets. 2025;24(2):102-114. doi: 10.2174/0118715273326866240922193029.

DOI:10.2174/0118715273326866240922193029
PMID:39354776
Abstract

Parkinson's Disease (PD) is a progressive disorder worldwide and its etiology remains unidentified. Over the last few decades, animal models of PD have been extensively utilized to explore the development and mechanisms of this neurodegenerative condition. Toxic and transgenic animal models for PD possess unique characteristics and constraints, necessitating careful consideration when selecting the appropriate model for research purposes. Animal models have played a significant role in uncovering the causes and development of PD, including its cellular and molecular processes. These models suggest that the disorder arises from intricate interplays between genetic predispositions and environmental influences. Every model possesses its unique set of strengths and weaknesses. This review provides a critical examination of animal models for PD and compares them with the features observed in the human manifestation of the disease.

摘要

帕金森病(PD)是一种全球性的进行性疾病,其病因尚未明确。在过去几十年中,帕金森病的动物模型已被广泛用于探索这种神经退行性疾病的发展和机制。帕金森病的毒性和转基因动物模型具有独特的特点和局限性,在选择适合研究目的的模型时需要仔细考虑。动物模型在揭示帕金森病的病因和发展,包括其细胞和分子过程方面发挥了重要作用。这些模型表明,该疾病源于遗传易感性和环境影响之间的复杂相互作用。每种模型都有其独特的优缺点。本综述对帕金森病的动物模型进行了批判性审视,并将它们与该疾病在人类表现中观察到的特征进行了比较。

相似文献

1
Modeling of Parkinson's Disease in Different Models.不同模型中帕金森病的建模
CNS Neurol Disord Drug Targets. 2025;24(2):102-114. doi: 10.2174/0118715273326866240922193029.
2
Classic and evolving animal models in Parkinson's disease.帕金森病的经典和演进动物模型。
Pharmacol Biochem Behav. 2020 Dec;199:173060. doi: 10.1016/j.pbb.2020.173060. Epub 2020 Oct 19.
3
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.帕金森病动物模型:弥合疾病特征与研究问题之间的差距。
Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.
4
Genetic animal models of Parkinson's disease.帕金森病的遗传动物模型。
Neuron. 2010 Jun 10;66(5):646-61. doi: 10.1016/j.neuron.2010.04.034.
5
Animal Models for Parkinson's Disease Research: Trends in the 2000s.帕金森病研究的动物模型:21 世纪的趋势。
Int J Mol Sci. 2019 Oct 30;20(21):5402. doi: 10.3390/ijms20215402.
6
Classic and new animal models of Parkinson's disease.帕金森病的经典和新型动物模型。
J Biomed Biotechnol. 2012;2012:845618. doi: 10.1155/2012/845618. Epub 2012 Mar 28.
7
Animal models of Parkinson's disease.帕金森病动物模型。
FEBS J. 2012 Apr;279(7):1156-66. doi: 10.1111/j.1742-4658.2012.08491.x. Epub 2012 Feb 28.
8
Convergent pathobiologic model of Parkinson's disease.帕金森病的趋同病理生物学模型
Ann N Y Acad Sci. 2003 Jun;991:152-66. doi: 10.1111/j.1749-6632.2003.tb07473.x.
9
Animal models of Parkinson's disease.帕金森病动物模型。
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S183-5. doi: 10.1016/S1353-8020(11)70057-8.
10
Engineered modeling and the secrets of Parkinson's disease.工程建模与帕金森病的奥秘。
Trends Neurosci. 2001 Nov;24(11 Suppl):S49-55. doi: 10.1016/s0166-2236(00)01984-6.

本文引用的文献

1
Parkinson's disease model in zebrafish using intraperitoneal MPTP injection.使用腹腔注射MPTP建立斑马鱼帕金森病模型。
Front Neurosci. 2023 Aug 25;17:1236049. doi: 10.3389/fnins.2023.1236049. eCollection 2023.
2
as a Model System to Study Human Neurodegenerative Disorders.作为研究人类神经退行性疾病的模型系统。
Biomolecules. 2023 Mar 5;13(3):478. doi: 10.3390/biom13030478.
3
Modelling Parkinson's Disease in : Strengths and Limitations.帕金森病模型研究:优势与局限。
Curr Pharm Des. 2022;28(37):3033-3048. doi: 10.2174/1381612828666220915103502.
4
Neurotoxicity of pesticides - A link to neurodegeneration.农药的神经毒性——与神经退行性变有关。
Ecotoxicol Environ Saf. 2022 Sep 15;243:113972. doi: 10.1016/j.ecoenv.2022.113972. Epub 2022 Aug 24.
5
A Critical Review of Zebrafish Models of Parkinson's Disease.帕金森病斑马鱼模型的批判性综述
Front Pharmacol. 2022 Mar 15;13:835827. doi: 10.3389/fphar.2022.835827. eCollection 2022.
6
Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2-driven Parkinson's disease.开发一种基于 LUHMES 细胞的、具有生理相关性且易于扩展的 G2019S LRRK2 驱动的帕金森病模型。
Dis Model Mech. 2021 Jun 1;14(6). doi: 10.1242/dmm.048017. Epub 2021 Jun 11.
7
Parkinson's disease.帕金森病。
Lancet. 2021 Jun 12;397(10291):2284-2303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10.
8
Biochemical characterization of proliferative and differentiated SH-SY5Y cell line as a model for Parkinson's disease.帕金森病模型 SH-SY5Y 细胞系的增殖和分化的生化特征。
Neurochem Int. 2021 May;145:105009. doi: 10.1016/j.neuint.2021.105009. Epub 2021 Mar 5.
9
Drosophila melanogaster a Versatile Model of Parkinson's Disease.果蝇是帕金森病的一种多用途模型。
CNS Neurol Disord Drug Targets. 2021;20(6):487-530. doi: 10.2174/1871527320666210208125912.
10
Role of luteolin in overcoming Parkinson's disease.木樨草素在克服帕金森病中的作用。
Biofactors. 2021 Mar;47(2):198-206. doi: 10.1002/biof.1706. Epub 2021 Jan 14.